David Mason

Certolizumab Pegol for the Treatment of Crohn's Disease

William J. Sandborn, Brian G. Feagan, S Stoĭnov et al. · New England Journal of Medicine · 2007 · 1.1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: Findings of a fifty‐two–week, phase III, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group study

Edward Keystone, Désirée van der Heijde, David Mason et al. · Arthritis & Rheumatism · 2008 · 577 citations

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy and safety of certolizumab pegol plus methotrexate in active rheumatoid arthritis: the RAPID 2 study. A randomised controlled trial

Josef S Smolen, R. B. M. Landewé, Philip J. Mease et al. · Annals of the Rheumatic Diseases · 2008 · 492 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Clinical and Mucosal Improvement With Specific Carbohydrate Diet in Pediatric Crohn Disease

Stanley A. Cohen, Benjamin D. Gold, Salvatore Oliva et al. · Journal of Pediatric Gastroenterology and Nutrition · 2014 · 230 citations

Agriculture, Nutrition, Pediatrics +17

Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come

Malcolm V. Brock, Craig M. Hooker, James E. Syphard et al. · Journal of Thoracic and Cardiovascular Surgery · 2004 · 194 citations · Full text

Medicine, Oncology, Surgery +16